InMode Ltd.

InMode Ltd. (INMD) priced its initial public offering on Aug 8, 2019 at $14.00 per share, raising $70M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $447.6M. Barclays was lead-left underwriter, joined by UBS, Canaccord Genuity and Baird. Primes, Shiloh, Givon, Meir Law Firm and Mayer Brown advised the company and Latham & Watkins advised the underwriters.

InMode Ltd. provides energy-based, minimally invasive surgical aesthetic and medical treatment products. Its radio frequency technologies are designed for face and body contouring, medical aesthetics and women's health, including treatments that remodel fat tissue and tighten skin.

Status

IPO

Ticker

INMD

Exchange

Nasdaq Global Select

Priced

Aug 8, 2019

IPO price

$14.00

Raised

$70M

Market cap at IPO price

$447.6M

First filed

Jul 11, 2019

Underwriters

Barclays, UBS, Canaccord Genuity and Baird

Company counsel

Primes, Shiloh, Givon, Meir Law Firm and Mayer Brown

Underwriters' counsel

Latham & Watkins

Sector

Healthcare

Country / state

Israel

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.